Template:Lymphoepithelioma: Difference between revisions

Jump to navigation Jump to search
Charmaine Patel (talk | contribs)
No edit summary
Charmaine Patel (talk | contribs)
No edit summary
 
(One intermediate revision by the same user not shown)
Line 28: Line 28:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Lymphoepithelioma classification|Classification]]
[[Lymphoepithelioma historical perspective|Historical Perspective]]
|-  
|-  
!
!
Line 34: Line 34:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Lymphoepithelioma historical perspective|Historical Perspective]]
[[Lymphoepithelioma classification|Classification]]
|-  
|-  
!
!
Line 46: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Lymphoepithelioma epidemiology and demographics|Epidemiology and Demographics]]
[[Lymphoepithelioma causes|Causes]]
|-  
|-  
!
!
Line 52: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Lymphoepithelioma risk factors|Risk Factors]]
[[Lymphoepithelioma epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 58: Line 58:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Lymphoepithelioma screening|Screening]]
[[Lymphoepithelioma risk factors|Risk Factors]]
|-  
|-  
!
!
Line 64: Line 64:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Lymphoepithelioma causes|Causes]]
[[Lymphoepithelioma screening|Screening]]
|-  
|-  
!
!
Line 192: Line 192:
[[Lymphoepithelioma future or investigational therapies|Future or Investigational Therapies]]
[[Lymphoepithelioma future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!
 
|- bgcolor="CadetBlue"
!
Case Studies
|-
!
 
|- bgcolor="PaleTurquoise"
!
[[Lymphepithelioma case study one|Case #1]]
|-
!


|- bgcolor="PaleGoldenrod "
|- bgcolor="PaleGoldenrod "

Latest revision as of 14:42, 18 September 2012